TEL-AVIV, Israel, Nov. 9, 2015 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), an Israeli biopharmaceutical company primarily focused on late clinical-stage, proprietary, orally-administered, small molecule drugs for inflammatory and gastrointestinal diseases, including cancer, today announced its financial results for the quarter ended September 30, 2015. - See more at: http://www.globenewswire.com/news-release/2015/11/09/785096/10155659/en/RedHill-Biopharma-Reports-Results-for-the-Third-Quarter-of-2015.html#sthash.XjIVWz33.dpuf
Help employers find you! Check out all the jobs and post your resume.
